Skip to content
Home/Companies/Biotech/Action Pharma

Action Pharma

Biotech·Denmark·Exited 2012·Held 10yr
Entry
2002
Hold
10yr
Exit
2012

Who owns Action Pharma?

Action Pharma is a Danish Biotech company, now owned by Abbott, which acquired it in 2012 from Capnova.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Capnova
Investor
Capnova
CAPNOVA · 1998 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Abbott
Exit Year
2012

More from CAPNOVA

Other portfolio companies in the same fund.

Triband
Exited 2020
GamingDenmark· 2016
to Triband ApS
SynAct Pharma
Exited 2016
BiotechDenmark· 2012
SYBO Games
Exited 2012
GamingDenmark· 2011
MediConnect
Exited 2005
HealthTechDenmark· 2001
to Kommuneinformation A/S (now part of EG)
Aros Applied Biotechnology
Exited 2013
BiotechDenmark· 2000
to Eurofins

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Action Pharma?

Action Pharma is now owned by Abbott, which acquired it in 2012 from Capnova.

When did Abbott acquire Action Pharma?

Abbott acquired Action Pharma in 2012, buying from Capnova.

Who did Action Pharma sell to?

Capnova sold Action Pharma to Abbott in 2012 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue